Streamlining Pulmonology Prior Authorizations with Surescripts Integration

Klivira's pulmonology Surescripts integration streamlines prior authorization workflows for high-cost biologics, home oxygen, and specialty medications critical for respiratory health. This integration connects your EMR directly to payer portals, automating ePA submissions and status checks.

Pulmonology practices face complex prior authorization requirements for specialty drugs and durable medical equipment, often leading to delays in patient care. Manual ePA processes for biologics like Dupixent or Nucala, or for home oxygen, consume significant staff time and are prone to errors. Klivira addresses these challenges by automating the entire Surescripts ePA workflow, enhancing efficiency and improving patient access.

The Prior Authorization Landscape in Pulmonology

Pulmonology prior authorizations are particularly complex due to the high cost and strict medical necessity criteria for specialty biologics, antifibrotics, and respiratory support equipment. Submitting these PAs manually through diverse payer portals is resource-intensive, often delaying access to essential treatments for conditions like severe asthma or idiopathic pulmonary fibrosis.

Common Pulmonology PA Triggers Automated by Surescripts

Asthma biologics (e.g., Dupixent, Nucala, Fasenra, Tezspire, Xolair)
IPF antifibrotics (e.g., pirfenidone, nintedanib)
COPD specialty drugs (e.g., ensifentrine, certain triple-therapy inhalers)
Home oxygen, BiPAP, and CPAP therapies
Lung transplant evaluations and immunosuppression
Pulmonary function testing (PFTs)

Leveraging Surescripts ePA for Pulmonology Workflows

Klivira integrates with the Surescripts ePA and eligibility platform to automate prior authorization submissions for pulmonology-specific medications and durable medical equipment. This connection facilitates real-time eligibility checks and submission of X12 278 transactions, streamlining the process directly from your EMR for high-volume PA categories like asthma biologics and home oxygen.

Evidence-Based PA Submissions for Respiratory Care

Accurate prior authorization submissions in pulmonology require adherence to clinical guidelines from bodies like ATS, GOLD for COPD, and GINA for asthma. Klivira's platform extracts relevant clinical data such as eosinophil counts, prior controller therapy history, and exacerbation frequency from your EMR to automatically populate PA forms, ensuring submissions meet payer medical necessity criteria and address common denial reasons like unmet step-therapy requirements.

Seamless EMR and Payer Portal Connectivity

Automated data extraction from EMR order sets for biologics and DMEs.
Direct submission of ePA requests via Surescripts to participating payers.
Real-time status updates and notifications pushed back into the EMR.
Integration with payer policy libraries to guide documentation requirements.
Support for specialty pharmacy ordering workflows for high-cost drugs.

Klivira's Impact on Pulmonology PA Efficiency

Klivira's specialized logic for pulmonology, informed by GINA/GOLD/ATS guidelines, automates step-therapy verification and eosinophil-count documentation. This targeted approach reduces manual effort, accelerates approval times for critical asthma biologics and antifibrotics, and minimizes denials, ensuring patients receive timely access to necessary respiratory care.

Frequently asked questions

How does Klivira handle asthma biologic prior authorizations with Surescripts?

Klivira automates the submission of ePA requests for asthma biologics like Dupixent or Nucala through Surescripts. The platform extracts required clinical data, such as eosinophil counts and prior controller therapy history, directly from your EMR to ensure compliance with payer step-therapy policies and medical necessity criteria.

Can Klivira automate prior authorizations for home oxygen and BiPAP?

Yes, Klivira's Surescripts integration extends to durable medical equipment (DME) like home oxygen and BiPAP. The system streamlines the submission of necessary documentation, including medical necessity forms and clinical notes, to facilitate faster approvals for these essential respiratory support therapies.

What EMR systems does Klivira integrate with for pulmonology workflows?

Klivira offers robust integration capabilities with leading EMR systems via SMART on FHIR and other standard interfaces. This ensures seamless data exchange for pulmonology prior authorizations, allowing clinical data to flow directly from your EMR to payer portals through the Surescripts platform.

How does Klivira address common denial reasons for pulmonology PAs?

Klivira's platform incorporates intelligent logic to proactively address common denial reasons, such as unmet step-therapy requirements or insufficient eosinophil counts for biologics. By guiding documentation and verifying criteria against payer policies and clinical guidelines (e.g., GINA, GOLD), Klivira helps ensure complete and accurate submissions.

Does Klivira support re-authorization workflows for long-term pulmonology therapies?

Yes, Klivira supports automated re-authorization workflows for long-term pulmonology therapies, including maintenance biologics and home oxygen. The system tracks authorization expiry dates and initiates re-submission processes with pre-populated data, minimizing lapses in coverage and ensuring continuous patient care.